AAAAAA

   
Results: 1-15 |
Results: 15
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR POTENTIATES ANTITUMOR-ACTIVITY OF INTERLEUKIN-12 IN MELANOMA MODEL IN MICE
Authors: GOLAB J STOKLOSA T ZAGOZDZON R KACA A KULCHITSKA LA FELESZKO W KAWIAK J HOSER G GLOWACKA E DABROWSKA A GIERMASZ A LASEK W JAKOBISIAK M
Citation: J. Golab et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR POTENTIATES ANTITUMOR-ACTIVITY OF INTERLEUKIN-12 IN MELANOMA MODEL IN MICE, Tumor biology, 19(2), 1998, pp. 77-87
POTENTIATED ANTITUMOR EFFECTS OF CISPLATIN AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE
Authors: FELESZKO W ZAGOZDZON R GOLAB J JAKOBISIAK M
Citation: W. Feleszko et al., POTENTIATED ANTITUMOR EFFECTS OF CISPLATIN AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE, European journal of cancer, 34(3), 1998, pp. 406-411
G-CSF PREVENTS THE SUPPRESSION OF BONE-MARROW HEMATOPOIESIS INDUCED BY IL-12 AND AUGMENTS ITS ANTITUMOR-ACTIVITY IN A MELANOMA MODEL IN MICE
Authors: GOLAB J STOKLOSA T ZAGOZDZON R KACA A GIERMASZ A POJDA Z MACHAJ E DABROWSKA A FELESZKO W LASEK W IWANOSIECKA A JAKOBISIAK M
Citation: J. Golab et al., G-CSF PREVENTS THE SUPPRESSION OF BONE-MARROW HEMATOPOIESIS INDUCED BY IL-12 AND AUGMENTS ITS ANTITUMOR-ACTIVITY IN A MELANOMA MODEL IN MICE, Annals of oncology, 9(1), 1998, pp. 63-69
TEST STRATEGY FOR THE POWERPC-750 MICROPROCESSOR
Authors: PYRON C PRADO J GOLAB J
Citation: C. Pyron et al., TEST STRATEGY FOR THE POWERPC-750 MICROPROCESSOR, IEEE design & test of computers, 15(3), 1998, pp. 90-97
GRANULOCYTE-COLONY-STIMULATING FACTOR DEMONSTRATES ANTITUMOR-ACTIVITYIN MELANOMA MODEL IN MICE
Authors: GOLAB J ZAGOZDZON R STOKLOSA T KACA A DABROWSKA A GIERMASZ A FELESZKO W JAKOBISIAK M
Citation: J. Golab et al., GRANULOCYTE-COLONY-STIMULATING FACTOR DEMONSTRATES ANTITUMOR-ACTIVITYIN MELANOMA MODEL IN MICE, Neoplasma, 45(1), 1998, pp. 35-39
EFFECTIVE CHEMOIMMUNOTHERAPY OF L1210 LEUKEMIA IN-VIVO USING INTERLEUKIN-12 COMBINED WITH DOXORUBICIN BUT NOT WITH CYCLOPHOSPHAMIDE, PACLITAXEL OR CISPLATIN
Authors: ZAGOZDZON R GOLAB J STOKLOSA T GIERMASZ A NOWICKA D FELESZKO W LASEK W JAKOBISIAK M
Citation: R. Zagozdzon et al., EFFECTIVE CHEMOIMMUNOTHERAPY OF L1210 LEUKEMIA IN-VIVO USING INTERLEUKIN-12 COMBINED WITH DOXORUBICIN BUT NOT WITH CYCLOPHOSPHAMIDE, PACLITAXEL OR CISPLATIN, International journal of cancer, 77(5), 1998, pp. 720-727
ERYTHROPOIETIN PREVENTS THE DEVELOPMENT OF INTERLEUKIN-12-INDUCED ANEMIA AND THROMBOCYTOPENIA BUT DOES NOT DECREASE ITS ANTITUMOR-ACTIVITY IN MICE
Authors: GOLAB J ZAGOZDZON R STOKLOSA T LASEK W JAKOBISIAK M POJDA Z MACHAJ E
Citation: J. Golab et al., ERYTHROPOIETIN PREVENTS THE DEVELOPMENT OF INTERLEUKIN-12-INDUCED ANEMIA AND THROMBOCYTOPENIA BUT DOES NOT DECREASE ITS ANTITUMOR-ACTIVITY IN MICE, Blood, 91(11), 1998, pp. 4387-4388
APOPTOSIS INDUCED IN L1210 LEUKEMIA-CELLS BY AN INHIBITOR OF THE CHYMOTRYPSIN-LIKE ACTIVITY OF THE PROTEASOME
Authors: WOJCIK C STOKLOSA T GIERMASZ A GOLAB J ZAGOZDZON R KAWIAK J WILK S KOMAR A KACA A MALEJCZYK J JAKOBISIAK M
Citation: C. Wojcik et al., APOPTOSIS INDUCED IN L1210 LEUKEMIA-CELLS BY AN INHIBITOR OF THE CHYMOTRYPSIN-LIKE ACTIVITY OF THE PROTEASOME, Apoptosis, 2(5), 1997, pp. 455-462
ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE
Authors: LASEK W FELESZKO W GOLAB J STOKLOSA T MARCZAK M DABROWSKA A MALEJCZYK M JAKOBISIAK M
Citation: W. Lasek et al., ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE, European journal of cancer, 33, 1997, pp. 22-22
ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE
Authors: LASEK W FELESZKO W GOLAB J STOKLOSA T MARCZAK M DABROWSKA A MALEJCZYK M JAKOBISIAK M
Citation: W. Lasek et al., ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE, Cancer immunology and immunotherapy, 45(2), 1997, pp. 100-108
AUGMENTED ANTITUMOR EFFECTS OF COMBINATION THERAPY WITH INTERLEUKIN-12, CISPLATIN, AND TUMOR-NECROSIS-FACTOR-ALPHA IN A MURINE MELANOMA MODEL
Authors: ZAGOZDZON R STOKLOSA T GOLAB J GIERMASZ A DABROWSKA A LASEK W JAKOBISIAK M
Citation: R. Zagozdzon et al., AUGMENTED ANTITUMOR EFFECTS OF COMBINATION THERAPY WITH INTERLEUKIN-12, CISPLATIN, AND TUMOR-NECROSIS-FACTOR-ALPHA IN A MURINE MELANOMA MODEL, Anticancer research, 17(6D), 1997, pp. 4493-4498
POTENTIATION OF THE ANTITUMOR EFFECT OF ACTINOMYCIN-D BY TUMOR-NECROSIS-FACTOR-ALPHA IN MICE - CORRELATION BETWEEN IN-VITRO AND IN-VIVO RESULTS
Authors: LASEK W GIERMASZ A KUC K WANKOWICZ A FELESZKO W GOLAB J ZAGOZDZON R STOKLOSA T JAKOBISIAK M
Citation: W. Lasek et al., POTENTIATION OF THE ANTITUMOR EFFECT OF ACTINOMYCIN-D BY TUMOR-NECROSIS-FACTOR-ALPHA IN MICE - CORRELATION BETWEEN IN-VITRO AND IN-VIVO RESULTS, International journal of cancer, 66(3), 1996, pp. 374-379
POTENTIATION OF ANTITUMOR EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA BY MACROPHAGE-COLONY-STIMULATING FACTOR IN A MMB16 MELANOMA MODEL IN MICE
Authors: LASEK W WANKOWICZ A KUC K FELESZKO W GOLAB J GIERMASZ A WIKTORJEDRZEJCZAK W JAKOBISIAK M
Citation: W. Lasek et al., POTENTIATION OF ANTITUMOR EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA BY MACROPHAGE-COLONY-STIMULATING FACTOR IN A MMB16 MELANOMA MODEL IN MICE, Cancer immunology and immunotherapy, 40(5), 1995, pp. 315-321
SYNERGISTIC ANTITUMOR-ACTIVITY OF TUMOR-NECROSIS-FACTOR-ALPHA AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE
Authors: FELESZKO W LASEK W GOLAB J JAKOBISIAK M
Citation: W. Feleszko et al., SYNERGISTIC ANTITUMOR-ACTIVITY OF TUMOR-NECROSIS-FACTOR-ALPHA AND LOVASTATIN AGAINST MMB16 MELANOMA IN MICE, Neoplasma, 42(2), 1995, pp. 69-74
A 2.2-W, 80-MHZ SUPERSCALAR RISC MICROPROCESSOR
Authors: GEROSA G GARY S DIETZ C PHAM D HOOVER K ALVAREZ J SANCHEZ H IPPOLITO P NGO T LITCH S ENO J GOLAB J VANDERSCHAAF N KAHLE J
Citation: G. Gerosa et al., A 2.2-W, 80-MHZ SUPERSCALAR RISC MICROPROCESSOR, IEEE journal of solid-state circuits, 29(12), 1994, pp. 1440-1454
Risultati: 1-15 |